Latest return on equity

20/20 Biolabs Return on equity

20/20 Biolabs (AIDX) return on equity with its verified observation date.

Direct answer

20/20 Biolabs's return on equity is -331.22%.

The verified market snapshot reports -331.22%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 23, 2026.

Get free 20/20 Biolabs email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Return on equity
-331.22%

Explore related company data

View 20/20 Biolabs's market capitalizationView 20/20 Biolabs's 52-week price rangeView 20/20 Biolabs's revenue growthView 20/20 Biolabs's profit marginView 20/20 Biolabs's debt-to-equity ratioView all 20/20 Biolabs key metricsReturn to 20/20 Biolabs profile